Bremelanotide (PT-141)

Product Name: Bremelanotide (PT-141)

Synonyms: N-Acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysine (2-7)-lactam

Cas No.: 189691-06-3

Molecular Formula: C50H68N14O10

Molecular Weight: 1025.16

Appearance : white powder

Details:

Absrtact Bremelanotide (formerly PT-141) is a compound under drug development by Palatin Technologies as a treatment for female sexual dysfunction, hemorrhagic shock and reperfusion injury. It functions by activating the melanocortin receptors MC1R and MC4R, to modulate inflammation and limitingischemia. It was originally tested for intranasal administration in treating female sexual dysfunctionbut this application was temporarily discontinued in 2008 after concerns were raised over adverse side effects of increased blood pressure. As of March, 2012, Palatin is conducting a human Phase 2B study using a new subcutaneous drug delivery system that appears to have little effect on blood pressure.



在线询价

至: Biopro Chemicals Co., Ltd.
Your E-mail:
消息正文:


Send to other suppliers

Other supplier products

Letrozole (Femara)
Letrozole (Femara)
GBL (gamma-Butyrolactone)
GBL (gamma-Butyrolactone)
Boldenone Acetate
Boldenone Acetate
Clomid (Clomiphene Citrate)
Clomid (Clomiphene Citrate)
Phentermine hydrochloride
Phentermine hydrochloride
供应产品

Same products

Pharmaceutical materials 卖方: Yuancheng Pharmaceutical Co.,Ltd
Pharmaceutical materials 卖方: Yuancheng Pharmaceutical Co.,Ltd
Pharmaceutical materials 卖方: Yuancheng Pharmaceutical Co.,Ltd
Pharmaceutical materials 卖方: Yuancheng Pharmaceutical Co.,Ltd
Pharmaceutical materials 卖方: Yuancheng Pharmaceutical Co.,Ltd